Literature DB >> 20211887

Trends in antimicrobial resistance of Acinetobacter baumannii isolates from a metropolitan Detroit health system.

Tara Reddy1, Teena Chopra, Dror Marchaim, Jason M Pogue, George Alangaden, Hossein Salimnia, Dina Boikov, Shiri Navon-Venezia, Robert Akins, Philip Selman, Sorabh Dhar, Keith S Kaye.   

Abstract

A phenotypic and genotypic analysis of Acinetobacter baumannii was conducted from 2003 to 2008 in Detroit, MI. The incidence of A. baumannii increased from 1.7 to 3.7/1,000 patient days during the study period. Susceptibility to ampicillin-sulbactam and imipenem decreased from approximately 90% to approximately 40%. Genotyping revealed polyclonality, suggesting either emergence of multiple resistant strains or spread of a common genetic element. The sharp rise mandates major multidisciplinary interventions to optimize management of this multidrug-resistant pathogen.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20211887      PMCID： PMC2863623          DOI： 10.1128/AAC.01665-09

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  27 in total

1.  Direct costs of multidrug-resistant Acinetobacter baumannii in the burn unit of a public teaching hospital.

Authors:  Stephen J Wilson; Cynthia J Knipe; Madeline J Zieger; Kari M Gabehart; Joyce E Goodman; Helen M Volk; Rajiv Sood
Journal:  Am J Infect Control       Date:  2004-10       Impact factor: 2.918

Review 2.  Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections.

Authors:  Matthew E Falagas; Sofia K Kasiakou
Journal:  Clin Infect Dis       Date:  2005-03-22       Impact factor: 9.079

3.  Influence of testing methodology on the tigecycline activity profile against presumably tigecycline-non-susceptible Acinetobacter spp.

Authors:  M Casal; F Rodríguez; B Johnson; E Garduno; F Tubau; R Ortiz de Lejarazu; A Tenorio; M J Giménez; R Bartolomé; C Garcia-Rey; L Aguilar; N García-Escribano
Journal:  J Antimicrob Chemother       Date:  2009-05-17       Impact factor: 5.790

Review 4.  Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing.

Authors:  F C Tenover; R D Arbeit; R V Goering; P A Mickelsen; B E Murray; D H Persing; B Swaminathan
Journal:  J Clin Microbiol       Date:  1995-09       Impact factor: 5.948

5.  PCR-based DNA fingerprinting (REP-PCR, AP-PCR) and pulsed-field gel electrophoresis characterization of a nosocomial outbreak caused by imipenem- and meropenem-resistant Acinetobacter baumannii.

Authors:  G Bou; G Cerveró; M A Domínguez; C Quereda; J Martínez-Beltrán
Journal:  Clin Microbiol Infect       Date:  2000-12       Impact factor: 8.067

6.  Distribution of repetitive DNA sequences in eubacteria and application to fingerprinting of bacterial genomes.

Authors:  J Versalovic; T Koeuth; J R Lupski
Journal:  Nucleic Acids Res       Date:  1991-12-25       Impact factor: 16.971

Review 7.  Treatment of Acinetobacter spp infections.

Authors:  Anna S Levin
Journal:  Expert Opin Pharmacother       Date:  2003-08       Impact factor: 3.889

Review 8.  Multidrug-resistant Acinetobacter infections: an emerging challenge to clinicians.

Authors:  Rupali Jain; Larry H Danziger
Journal:  Ann Pharmacother       Date:  2004-07-27       Impact factor: 3.154

9.  A comparative study of different PCR-based DNA fingerprinting techniques for typing of the Acinetobacter calcoaceticus-A. baumannii complex.

Authors:  J Vila; M A Marcos; M T Jimenez de Anta
Journal:  J Med Microbiol       Date:  1996-06       Impact factor: 2.472

10.  Multidrug-resistant Acinetobacter baumannii.

Authors:  Aharon Abbo; Shiri Navon-Venezia; Orly Hammer-Muntz; Tami Krichali; Yardena Siegman-Igra; Yehuda Carmeli
Journal:  Emerg Infect Dis       Date:  2005-01       Impact factor: 6.883
View more
  22 in total

Review 1.  Acinetobacter baumannii: evolution of antimicrobial resistance-treatment options.

Authors:  Yohei Doi; Gerald L Murray; Anton Y Peleg
Journal:  Semin Respir Crit Care Med       Date:  2015-02-02       Impact factor: 3.119

2.  A short synthetic peptide, based on LyeTx I from Lycosa erythrognatha venom, shows potential to treat pneumonia caused by carbapenem-resistant Acinetobacter baumannii without detectable resistance.

Authors:  William Gustavo Lima; Júlio César Moreira Brito; Maria Elena de Lima; Amanda Cristina Silva Tardelli Pizarro; Maria Auxiliadora Martins de Mello Vianna; Magna Cristina de Paiva; Débora Cristina Sampaio de Assis; Valbert Nascimento Cardoso; Simone Odília Antunes Fernandes
Journal:  J Antibiot (Tokyo)       Date:  2021-05-10       Impact factor: 2.649

3.  Colistin-resistant Acinetobacter baumannii: beyond carbapenem resistance.

Authors:  Zubair A Qureshi; Lauren E Hittle; Jessica A O'Hara; Jesabel I Rivera; Alveena Syed; Ryan K Shields; Anthony W Pasculle; Robert K Ernst; Yohei Doi
Journal:  Clin Infect Dis       Date:  2015-01-28       Impact factor: 9.079

Review 4.  Treatment options for carbapenem-resistant and extensively drug-resistant Acinetobacter baumannii infections.

Authors:  J Alexander Viehman; M Hong Nguyen; Yohei Doi
Journal:  Drugs       Date:  2014-08       Impact factor: 9.546

5.  Epidemiology of bloodstream infections caused by Acinetobacter baumannii and impact of drug resistance to both carbapenems and ampicillin-sulbactam on clinical outcomes.

Authors:  Teena Chopra; Dror Marchaim; Reda A Awali; Amar Krishna; Paul Johnson; Ryan Tansek; Khawar Chaudary; Paul Lephart; Jessica Slim; Jatinder Hothi; Harris Ahmed; Jason M Pogue; Jing J Zhao; Keith S Kaye
Journal:  Antimicrob Agents Chemother       Date:  2013-10-07       Impact factor: 5.191

6.  Azithromycin attenuates lung inflammation in a mouse model of ventilator-associated pneumonia by multidrug-resistant Acinetobacter baumannii.

Authors:  Koichi Yamada; Katsunori Yanagihara; Norihito Kaku; Yosuke Harada; Yohei Migiyama; Kentaro Nagaoka; Yoshitomo Morinaga; Shigeki Nakamura; Yoshifumi Imamura; Taiga Miyazaki; Koichi Izumikawa; Hiroshi Kakeya; Hiroo Hasegawa; Hiroshige Mikamo; Shigeru Kohno
Journal:  Antimicrob Agents Chemother       Date:  2013-06-03       Impact factor: 5.191

7.  Clinical and Epidemiological Significance of Carbapenem Resistance in Acinetobacter baumannii Infections.

Authors:  Ruthy Tal-Jasper; David E Katz; Nadav Amrami; Dor Ravid; Dori Avivi; Ronit Zaidenstein; Tsilia Lazarovitch; Mor Dadon; Keith S Kaye; Dror Marchaim
Journal:  Antimicrob Agents Chemother       Date:  2016-04-22       Impact factor: 5.191

8.  Rate of polymyxin resistance among Acinetobacter baumannii recovered from hospitalized patients: a systematic review and meta-analysis.

Authors:  William Gustavo Lima; Júlio César Moreira Brito; Bárbara Gatti Cardoso; Valbert Nascimento Cardoso; Magna Cristina de Paiva; Maria Elena de Lima; Simone Odília Antunes Fernandes
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2020-06-12       Impact factor: 3.267

9.  Pathogenicity of ocular isolates of Acinetobacter baumannii in a mouse model of bacterial endophthalmitis.

Authors:  Deepa Talreja; Keith S Kaye; Fu-shin Yu; Satish K Walia; Ashok Kumar
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-04-15       Impact factor: 4.799

10.  Studies on New Delhi Metallo-Beta-Lactamse-1 producing Acinetobacter baumannii isolated from donor swab in a tertiary eye care centre, India and structural analysis of its antibiotic binding interactions.

Authors:  Murali Sowmiya; Vetrivel Umashankar; Sivashanmugan Muthukumaran; Hajib Naraharirao Madhavan; Jambulingam Malathi
Journal:  Bioinformation       Date:  2012-05-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.